Global Retinal Degenerative Disease Treatment Drugs Supply, Demand and Key Producers, 2024-2030

Description

The global Retinal Degenerative Disease Treatment Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Retinal Degenerative Disease Treatment Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Retinal Degenerative Disease Treatment Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Retinal Degenerative Disease Treatment Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Retinal Degenerative Disease Treatment Drugs total production and demand, 2019-2030, (K Units)
Global Retinal Degenerative Disease Treatment Drugs total production value, 2019-2030, (USD Million)
Global Retinal Degenerative Disease Treatment Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Retinal Degenerative Disease Treatment Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Retinal Degenerative Disease Treatment Drugs domestic production, consumption, key domestic manufacturers and share
Global Retinal Degenerative Disease Treatment Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Retinal Degenerative Disease Treatment Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Retinal Degenerative Disease Treatment Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Retinal Degenerative Disease Treatment Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma, Merck, Takeda, Valeant Pharmaceuticals International，Inc and Oxurion（ThromboGenics）, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Retinal Degenerative Disease Treatment Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Retinal Degenerative Disease Treatment Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Retinal Degenerative Disease Treatment Drugs Market, Segmentation by Type
    Age Related Macular Degeneration (AMD) Treatment Drug
    Retinitis Pigmentosa (RP) Treatment Drug

Global Retinal Degenerative Disease Treatment Drugs Market, Segmentation by Application
    Hospital
    Clinic
    Others

Companies Profiled:
    Regeneron Pharmaceuticals
    Bayer HealthCare
    Novartis
    Roche
    Kanghong Pharma
    Merck
    Takeda
    Valeant Pharmaceuticals International，Inc
    Oxurion（ThromboGenics）
    Santen Pharmaceutical
    jCyte, Inc.
    Kodiak Sciences
    Coherus BioSciences, Inc

Key Questions Answered
1. How big is the global Retinal Degenerative Disease Treatment Drugs market?
2. What is the demand of the global Retinal Degenerative Disease Treatment Drugs market?
3. What is the year over year growth of the global Retinal Degenerative Disease Treatment Drugs market?
4. What is the production and production value of the global Retinal Degenerative Disease Treatment Drugs market?
5. Who are the key producers in the global Retinal Degenerative Disease Treatment Drugs market?

Table of Contents

1 Supply Summary
    1.1 Retinal Degenerative Disease Treatment Drugs Introduction
    1.2 World Retinal Degenerative Disease Treatment Drugs Supply & Forecast
        1.2.1 World Retinal Degenerative Disease Treatment Drugs Production Value (2019 & 2023 & 2030)
        1.2.2 World Retinal Degenerative Disease Treatment Drugs Production (2019-2030)
        1.2.3 World Retinal Degenerative Disease Treatment Drugs Pricing Trends (2019-2030)
    1.3 World Retinal Degenerative Disease Treatment Drugs Production by Region (Based on Production Site)
        1.3.1 World Retinal Degenerative Disease Treatment Drugs Production Value by Region (2019-2030)
        1.3.2 World Retinal Degenerative Disease Treatment Drugs Production by Region (2019-2030)
        1.3.3 World Retinal Degenerative Disease Treatment Drugs Average Price by Region (2019-2030)
        1.3.4 North America Retinal Degenerative Disease Treatment Drugs Production (2019-2030)
        1.3.5 Europe Retinal Degenerative Disease Treatment Drugs Production (2019-2030)
        1.3.6 China Retinal Degenerative Disease Treatment Drugs Production (2019-2030)
        1.3.7 Japan Retinal Degenerative Disease Treatment Drugs Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Retinal Degenerative Disease Treatment Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Retinal Degenerative Disease Treatment Drugs Major Market Trends

2 Demand Summary
    2.1 World Retinal Degenerative Disease Treatment Drugs Demand (2019-2030)
    2.2 World Retinal Degenerative Disease Treatment Drugs Consumption by Region
        2.2.1 World Retinal Degenerative Disease Treatment Drugs Consumption by Region (2019-2024)
        2.2.2 World Retinal Degenerative Disease Treatment Drugs Consumption Forecast by Region (2025-2030)
    2.3 United States Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030)
    2.4 China Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030)
    2.5 Europe Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030)
    2.6 Japan Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030)
    2.7 South Korea Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030)
    2.8 ASEAN Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030)
    2.9 India Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030)

3 World Retinal Degenerative Disease Treatment Drugs Manufacturers Competitive Analysis
    3.1 World Retinal Degenerative Disease Treatment Drugs Production Value by Manufacturer (2019-2024)
    3.2 World Retinal Degenerative Disease Treatment Drugs Production by Manufacturer (2019-2024)
    3.3 World Retinal Degenerative Disease Treatment Drugs Average Price by Manufacturer (2019-2024)
    3.4 Retinal Degenerative Disease Treatment Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Retinal Degenerative Disease Treatment Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Retinal Degenerative Disease Treatment Drugs in 2023
        3.5.3 Global Concentration Ratios (CR8) for Retinal Degenerative Disease Treatment Drugs in 2023
    3.6 Retinal Degenerative Disease Treatment Drugs Market: Overall Company Footprint Analysis
        3.6.1 Retinal Degenerative Disease Treatment Drugs Market: Region Footprint
        3.6.2 Retinal Degenerative Disease Treatment Drugs Market: Company Product Type Footprint
        3.6.3 Retinal Degenerative Disease Treatment Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Retinal Degenerative Disease Treatment Drugs Production Value Comparison
        4.1.1 United States VS China: Retinal Degenerative Disease Treatment Drugs Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Retinal Degenerative Disease Treatment Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Retinal Degenerative Disease Treatment Drugs Production Comparison
        4.2.1 United States VS China: Retinal Degenerative Disease Treatment Drugs Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Retinal Degenerative Disease Treatment Drugs Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Retinal Degenerative Disease Treatment Drugs Consumption Comparison
        4.3.1 United States VS China: Retinal Degenerative Disease Treatment Drugs Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Retinal Degenerative Disease Treatment Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Retinal Degenerative Disease Treatment Drugs Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Retinal Degenerative Disease Treatment Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production (2019-2024)
    4.5 China Based Retinal Degenerative Disease Treatment Drugs Manufacturers and Market Share
        4.5.1 China Based Retinal Degenerative Disease Treatment Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Value (2019-2024)
        4.5.3 China Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production (2019-2024)
    4.6 Rest of World Based Retinal Degenerative Disease Treatment Drugs Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Retinal Degenerative Disease Treatment Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production (2019-2024)

5 Market Analysis by Type
    5.1 World Retinal Degenerative Disease Treatment Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Age Related Macular Degeneration (AMD) Treatment Drug
        5.2.2 Retinitis Pigmentosa (RP) Treatment Drug
    5.3 Market Segment by Type
        5.3.1 World Retinal Degenerative Disease Treatment Drugs Production by Type (2019-2030)
        5.3.2 World Retinal Degenerative Disease Treatment Drugs Production Value by Type (2019-2030)
        5.3.3 World Retinal Degenerative Disease Treatment Drugs Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Retinal Degenerative Disease Treatment Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Retinal Degenerative Disease Treatment Drugs Production by Application (2019-2030)
        6.3.2 World Retinal Degenerative Disease Treatment Drugs Production Value by Application (2019-2030)
        6.3.3 World Retinal Degenerative Disease Treatment Drugs Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Regeneron Pharmaceuticals
        7.1.1 Regeneron Pharmaceuticals Details
        7.1.2 Regeneron Pharmaceuticals Major Business
        7.1.3 Regeneron Pharmaceuticals Retinal Degenerative Disease Treatment Drugs Product and Services
        7.1.4 Regeneron Pharmaceuticals Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Regeneron Pharmaceuticals Recent Developments/Updates
        7.1.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
    7.2 Bayer HealthCare
        7.2.1 Bayer HealthCare Details
        7.2.2 Bayer HealthCare Major Business
        7.2.3 Bayer HealthCare Retinal Degenerative Disease Treatment Drugs Product and Services
        7.2.4 Bayer HealthCare Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Bayer HealthCare Recent Developments/Updates
        7.2.6 Bayer HealthCare Competitive Strengths & Weaknesses
    7.3 Novartis
        7.3.1 Novartis Details
        7.3.2 Novartis Major Business
        7.3.3 Novartis Retinal Degenerative Disease Treatment Drugs Product and Services
        7.3.4 Novartis Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Novartis Recent Developments/Updates
        7.3.6 Novartis Competitive Strengths & Weaknesses
    7.4 Roche
        7.4.1 Roche Details
        7.4.2 Roche Major Business
        7.4.3 Roche Retinal Degenerative Disease Treatment Drugs Product and Services
        7.4.4 Roche Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Roche Recent Developments/Updates
        7.4.6 Roche Competitive Strengths & Weaknesses
    7.5 Kanghong Pharma
        7.5.1 Kanghong Pharma Details
        7.5.2 Kanghong Pharma Major Business
        7.5.3 Kanghong Pharma Retinal Degenerative Disease Treatment Drugs Product and Services
        7.5.4 Kanghong Pharma Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Kanghong Pharma Recent Developments/Updates
        7.5.6 Kanghong Pharma Competitive Strengths & Weaknesses
    7.6 Merck
        7.6.1 Merck Details
        7.6.2 Merck Major Business
        7.6.3 Merck Retinal Degenerative Disease Treatment Drugs Product and Services
        7.6.4 Merck Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Merck Recent Developments/Updates
        7.6.6 Merck Competitive Strengths & Weaknesses
    7.7 Takeda
        7.7.1 Takeda Details
        7.7.2 Takeda Major Business
        7.7.3 Takeda Retinal Degenerative Disease Treatment Drugs Product and Services
        7.7.4 Takeda Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Takeda Recent Developments/Updates
        7.7.6 Takeda Competitive Strengths & Weaknesses
    7.8 Valeant Pharmaceuticals International，Inc
        7.8.1 Valeant Pharmaceuticals International，Inc Details
        7.8.2 Valeant Pharmaceuticals International，Inc Major Business
        7.8.3 Valeant Pharmaceuticals International，Inc Retinal Degenerative Disease Treatment Drugs Product and Services
        7.8.4 Valeant Pharmaceuticals International，Inc Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Valeant Pharmaceuticals International，Inc Recent Developments/Updates
        7.8.6 Valeant Pharmaceuticals International，Inc Competitive Strengths & Weaknesses
    7.9 Oxurion（ThromboGenics）
        7.9.1 Oxurion（ThromboGenics） Details
        7.9.2 Oxurion（ThromboGenics） Major Business
        7.9.3 Oxurion（ThromboGenics） Retinal Degenerative Disease Treatment Drugs Product and Services
        7.9.4 Oxurion（ThromboGenics） Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Oxurion（ThromboGenics） Recent Developments/Updates
        7.9.6 Oxurion（ThromboGenics） Competitive Strengths & Weaknesses
    7.10 Santen Pharmaceutical
        7.10.1 Santen Pharmaceutical Details
        7.10.2 Santen Pharmaceutical Major Business
        7.10.3 Santen Pharmaceutical Retinal Degenerative Disease Treatment Drugs Product and Services
        7.10.4 Santen Pharmaceutical Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Santen Pharmaceutical Recent Developments/Updates
        7.10.6 Santen Pharmaceutical Competitive Strengths & Weaknesses
    7.11 jCyte, Inc.
        7.11.1 jCyte, Inc. Details
        7.11.2 jCyte, Inc. Major Business
        7.11.3 jCyte, Inc. Retinal Degenerative Disease Treatment Drugs Product and Services
        7.11.4 jCyte, Inc. Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 jCyte, Inc. Recent Developments/Updates
        7.11.6 jCyte, Inc. Competitive Strengths & Weaknesses
    7.12 Kodiak Sciences
        7.12.1 Kodiak Sciences Details
        7.12.2 Kodiak Sciences Major Business
        7.12.3 Kodiak Sciences Retinal Degenerative Disease Treatment Drugs Product and Services
        7.12.4 Kodiak Sciences Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Kodiak Sciences Recent Developments/Updates
        7.12.6 Kodiak Sciences Competitive Strengths & Weaknesses
    7.13 Coherus BioSciences, Inc
        7.13.1 Coherus BioSciences, Inc Details
        7.13.2 Coherus BioSciences, Inc Major Business
        7.13.3 Coherus BioSciences, Inc Retinal Degenerative Disease Treatment Drugs Product and Services
        7.13.4 Coherus BioSciences, Inc Retinal Degenerative Disease Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Coherus BioSciences, Inc Recent Developments/Updates
        7.13.6 Coherus BioSciences, Inc Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Retinal Degenerative Disease Treatment Drugs Industry Chain
    8.2 Retinal Degenerative Disease Treatment Drugs Upstream Analysis
        8.2.1 Retinal Degenerative Disease Treatment Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Retinal Degenerative Disease Treatment Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Retinal Degenerative Disease Treatment Drugs Production Mode
    8.6 Retinal Degenerative Disease Treatment Drugs Procurement Model
    8.7 Retinal Degenerative Disease Treatment Drugs Industry Sales Model and Sales Channels
        8.7.1 Retinal Degenerative Disease Treatment Drugs Sales Model
        8.7.2 Retinal Degenerative Disease Treatment Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Retinal Degenerative Disease Treatment Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Retinal Degenerative Disease Treatment Drugs Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Retinal Degenerative Disease Treatment Drugs Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Retinal Degenerative Disease Treatment Drugs Production Value Market Share by Region (2019-2024)
    Table 5. World Retinal Degenerative Disease Treatment Drugs Production Value Market Share by Region (2025-2030)
    Table 6. World Retinal Degenerative Disease Treatment Drugs Production by Region (2019-2024) & (K Units)
    Table 7. World Retinal Degenerative Disease Treatment Drugs Production by Region (2025-2030) & (K Units)
    Table 8. World Retinal Degenerative Disease Treatment Drugs Production Market Share by Region (2019-2024)
    Table 9. World Retinal Degenerative Disease Treatment Drugs Production Market Share by Region (2025-2030)
    Table 10. World Retinal Degenerative Disease Treatment Drugs Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Retinal Degenerative Disease Treatment Drugs Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Retinal Degenerative Disease Treatment Drugs Major Market Trends
    Table 13. World Retinal Degenerative Disease Treatment Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Retinal Degenerative Disease Treatment Drugs Consumption by Region (2019-2024) & (K Units)
    Table 15. World Retinal Degenerative Disease Treatment Drugs Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Retinal Degenerative Disease Treatment Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Retinal Degenerative Disease Treatment Drugs Producers in 2023
    Table 18. World Retinal Degenerative Disease Treatment Drugs Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Retinal Degenerative Disease Treatment Drugs Producers in 2023
    Table 20. World Retinal Degenerative Disease Treatment Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Retinal Degenerative Disease Treatment Drugs Company Evaluation Quadrant
    Table 22. World Retinal Degenerative Disease Treatment Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Retinal Degenerative Disease Treatment Drugs Production Site of Key Manufacturer
    Table 24. Retinal Degenerative Disease Treatment Drugs Market: Company Product Type Footprint
    Table 25. Retinal Degenerative Disease Treatment Drugs Market: Company Product Application Footprint
    Table 26. Retinal Degenerative Disease Treatment Drugs Competitive Factors
    Table 27. Retinal Degenerative Disease Treatment Drugs New Entrant and Capacity Expansion Plans
    Table 28. Retinal Degenerative Disease Treatment Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Retinal Degenerative Disease Treatment Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Retinal Degenerative Disease Treatment Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Retinal Degenerative Disease Treatment Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Retinal Degenerative Disease Treatment Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Market Share (2019-2024)
    Table 37. China Based Retinal Degenerative Disease Treatment Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Market Share (2019-2024)
    Table 42. Rest of World Based Retinal Degenerative Disease Treatment Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Market Share (2019-2024)
    Table 47. World Retinal Degenerative Disease Treatment Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Retinal Degenerative Disease Treatment Drugs Production by Type (2019-2024) & (K Units)
    Table 49. World Retinal Degenerative Disease Treatment Drugs Production by Type (2025-2030) & (K Units)
    Table 50. World Retinal Degenerative Disease Treatment Drugs Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Retinal Degenerative Disease Treatment Drugs Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Retinal Degenerative Disease Treatment Drugs Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Retinal Degenerative Disease Treatment Drugs Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Retinal Degenerative Disease Treatment Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Retinal Degenerative Disease Treatment Drugs Production by Application (2019-2024) & (K Units)
    Table 56. World Retinal Degenerative Disease Treatment Drugs Production by Application (2025-2030) & (K Units)
    Table 57. World Retinal Degenerative Disease Treatment Drugs Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Retinal Degenerative Disease Treatment Drugs Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Retinal Degenerative Disease Treatment Drugs Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Retinal Degenerative Disease Treatment Drugs Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 62. Regeneron Pharmaceuticals Major Business
    Table 63. Regeneron Pharmaceuticals Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 64. Regeneron Pharmaceuticals Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Regeneron Pharmaceuticals Recent Developments/Updates
    Table 66. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
    Table 67. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
    Table 68. Bayer HealthCare Major Business
    Table 69. Bayer HealthCare Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 70. Bayer HealthCare Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Bayer HealthCare Recent Developments/Updates
    Table 72. Bayer HealthCare Competitive Strengths & Weaknesses
    Table 73. Novartis Basic Information, Manufacturing Base and Competitors
    Table 74. Novartis Major Business
    Table 75. Novartis Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 76. Novartis Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Novartis Recent Developments/Updates
    Table 78. Novartis Competitive Strengths & Weaknesses
    Table 79. Roche Basic Information, Manufacturing Base and Competitors
    Table 80. Roche Major Business
    Table 81. Roche Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 82. Roche Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Roche Recent Developments/Updates
    Table 84. Roche Competitive Strengths & Weaknesses
    Table 85. Kanghong Pharma Basic Information, Manufacturing Base and Competitors
    Table 86. Kanghong Pharma Major Business
    Table 87. Kanghong Pharma Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 88. Kanghong Pharma Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Kanghong Pharma Recent Developments/Updates
    Table 90. Kanghong Pharma Competitive Strengths & Weaknesses
    Table 91. Merck Basic Information, Manufacturing Base and Competitors
    Table 92. Merck Major Business
    Table 93. Merck Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 94. Merck Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Merck Recent Developments/Updates
    Table 96. Merck Competitive Strengths & Weaknesses
    Table 97. Takeda Basic Information, Manufacturing Base and Competitors
    Table 98. Takeda Major Business
    Table 99. Takeda Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 100. Takeda Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Takeda Recent Developments/Updates
    Table 102. Takeda Competitive Strengths & Weaknesses
    Table 103. Valeant Pharmaceuticals International，Inc Basic Information, Manufacturing Base and Competitors
    Table 104. Valeant Pharmaceuticals International，Inc Major Business
    Table 105. Valeant Pharmaceuticals International，Inc Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 106. Valeant Pharmaceuticals International，Inc Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Valeant Pharmaceuticals International，Inc Recent Developments/Updates
    Table 108. Valeant Pharmaceuticals International，Inc Competitive Strengths & Weaknesses
    Table 109. Oxurion（ThromboGenics） Basic Information, Manufacturing Base and Competitors
    Table 110. Oxurion（ThromboGenics） Major Business
    Table 111. Oxurion（ThromboGenics） Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 112. Oxurion（ThromboGenics） Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. Oxurion（ThromboGenics） Recent Developments/Updates
    Table 114. Oxurion（ThromboGenics） Competitive Strengths & Weaknesses
    Table 115. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 116. Santen Pharmaceutical Major Business
    Table 117. Santen Pharmaceutical Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 118. Santen Pharmaceutical Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. Santen Pharmaceutical Recent Developments/Updates
    Table 120. Santen Pharmaceutical Competitive Strengths & Weaknesses
    Table 121. jCyte, Inc. Basic Information, Manufacturing Base and Competitors
    Table 122. jCyte, Inc. Major Business
    Table 123. jCyte, Inc. Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 124. jCyte, Inc. Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. jCyte, Inc. Recent Developments/Updates
    Table 126. jCyte, Inc. Competitive Strengths & Weaknesses
    Table 127. Kodiak Sciences Basic Information, Manufacturing Base and Competitors
    Table 128. Kodiak Sciences Major Business
    Table 129. Kodiak Sciences Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 130. Kodiak Sciences Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 131. Kodiak Sciences Recent Developments/Updates
    Table 132. Coherus BioSciences, Inc Basic Information, Manufacturing Base and Competitors
    Table 133. Coherus BioSciences, Inc Major Business
    Table 134. Coherus BioSciences, Inc Retinal Degenerative Disease Treatment Drugs Product and Services
    Table 135. Coherus BioSciences, Inc Retinal Degenerative Disease Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 136. Global Key Players of Retinal Degenerative Disease Treatment Drugs Upstream (Raw Materials)
    Table 137. Retinal Degenerative Disease Treatment Drugs Typical Customers
    Table 138. Retinal Degenerative Disease Treatment Drugs Typical Distributors
List of Figure
    Figure 1. Retinal Degenerative Disease Treatment Drugs Picture
    Figure 2. World Retinal Degenerative Disease Treatment Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Retinal Degenerative Disease Treatment Drugs Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Retinal Degenerative Disease Treatment Drugs Production (2019-2030) & (K Units)
    Figure 5. World Retinal Degenerative Disease Treatment Drugs Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Retinal Degenerative Disease Treatment Drugs Production Value Market Share by Region (2019-2030)
    Figure 7. World Retinal Degenerative Disease Treatment Drugs Production Market Share by Region (2019-2030)
    Figure 8. North America Retinal Degenerative Disease Treatment Drugs Production (2019-2030) & (K Units)
    Figure 9. Europe Retinal Degenerative Disease Treatment Drugs Production (2019-2030) & (K Units)
    Figure 10. China Retinal Degenerative Disease Treatment Drugs Production (2019-2030) & (K Units)
    Figure 11. Japan Retinal Degenerative Disease Treatment Drugs Production (2019-2030) & (K Units)
    Figure 12. Retinal Degenerative Disease Treatment Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030) & (K Units)
    Figure 15. World Retinal Degenerative Disease Treatment Drugs Consumption Market Share by Region (2019-2030)
    Figure 16. United States Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030) & (K Units)
    Figure 17. China Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030) & (K Units)
    Figure 18. Europe Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030) & (K Units)
    Figure 19. Japan Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030) & (K Units)
    Figure 22. India Retinal Degenerative Disease Treatment Drugs Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Retinal Degenerative Disease Treatment Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Retinal Degenerative Disease Treatment Drugs Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Retinal Degenerative Disease Treatment Drugs Markets in 2023
    Figure 26. United States VS China: Retinal Degenerative Disease Treatment Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Retinal Degenerative Disease Treatment Drugs Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Retinal Degenerative Disease Treatment Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Market Share 2023
    Figure 30. China Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Retinal Degenerative Disease Treatment Drugs Production Market Share 2023
    Figure 32. World Retinal Degenerative Disease Treatment Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Retinal Degenerative Disease Treatment Drugs Production Value Market Share by Type in 2023
    Figure 34. Age Related Macular Degeneration (AMD) Treatment Drug
    Figure 35. Retinitis Pigmentosa (RP) Treatment Drug
    Figure 36. World Retinal Degenerative Disease Treatment Drugs Production Market Share by Type (2019-2030)
    Figure 37. World Retinal Degenerative Disease Treatment Drugs Production Value Market Share by Type (2019-2030)
    Figure 38. World Retinal Degenerative Disease Treatment Drugs Average Price by Type (2019-2030) & (US$/Unit)
    Figure 39. World Retinal Degenerative Disease Treatment Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 40. World Retinal Degenerative Disease Treatment Drugs Production Value Market Share by Application in 2023
    Figure 41. Hospital
    Figure 42. Clinic
    Figure 43. Others
    Figure 44. World Retinal Degenerative Disease Treatment Drugs Production Market Share by Application (2019-2030)
    Figure 45. World Retinal Degenerative Disease Treatment Drugs Production Value Market Share by Application (2019-2030)
    Figure 46. World Retinal Degenerative Disease Treatment Drugs Average Price by Application (2019-2030) & (US$/Unit)
    Figure 47. Retinal Degenerative Disease Treatment Drugs Industry Chain
    Figure 48. Retinal Degenerative Disease Treatment Drugs Procurement Model
    Figure 49. Retinal Degenerative Disease Treatment Drugs Sales Model
    Figure 50. Retinal Degenerative Disease Treatment Drugs Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Companies Mentioned

Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Merck
Takeda
Valeant Pharmaceuticals International，Inc
Oxurion（ThromboGenics）
Santen Pharmaceutical
jCyte, Inc.
Kodiak Sciences
Coherus BioSciences, Inc